Source: International Congress 2014 – COPD markers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Huba, L. Konopkina, T. Pertseva (Dnipropetrovs'k, Ukraine). Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts). Eur Respir J 2014; 44: Suppl. 58, 4721

Member's Comments

No comment yet.

Related content which might interest you: Beck depression inventory-II: Determination and comparison of its diagnostic accuracy in asthmatic outpatients Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Clinical COPD questionnaire (CCQ) score and mortality Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Depression in chronic obstructive pulmonary disease: Predictors and accuracy of the hospital anxiety and depression scale (HADS) Source: International Congress 2014 – Latest insights in chronic care Year: 2014 Development of the morning activities and symptoms questionnaire (MASQ) for COPD Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008 Validity and reliability of the symptom domain of the clinical COPD questionnaire (CCQ) Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006 Does adding the Generalised Anxiety Disorder (GAD) questionnaire and Patient Health Questionnaire-9 (PHQ-9) to routine outpatient activity provide more information on the presence of anxiety and depression in asthma? Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 Management of depression and anxiety in COPD Source: Eur Respir Mon 2013; 59: 144-163 Year: 2013 Depressive symptomatology in COPD patients Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 The relationship between dyspnea and detection of depression in COPD patients (pts) Source: International Congress 2015 – Different data in COPD Year: 2015 Testing the validity of a self-administered questionnaire version of the transition dyspnea index in COPD patients Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases Year: 2016 The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Satisfaction with asthma treatment questionnaire, (SATQ) Source: Eur Respir J 2002; 20: Suppl. 38, 203s Year: 2002 How to value clinical presentation (symptom score, QoL questionnaires) Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Discordant symptom severity in COPD: The PHAROAH study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Symptom scoring in COPD patients Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008 Validity of COPD assessment test (CAT) in patients with cardiovascular co-morbidities Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Symptoms of anxiety and depression and CAT scores in COPD patients entering pulmonary rehabilitation Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007 Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013